Mylan
1000 Mylan Boulevard
Canonsburg
Pennsylvania
15317
United States
Tel: 724-514-1800
Website: http://www.mylan.com/
About Mylan
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, Mylan innovates to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership
YEAR FOUNDED:
1961
LEADERSHIP:
Founders: Milan Puskar, and Don Panoz
CEO: Heather Bresch
CFO: Neil Dimick
PRODUCTS:
All Products
991 articles about Mylan
-
Pfizer Inc. Sues Apotex Inc., Mylan Inc. to Block Generic Viagra
11/1/2010
-
Third Circuit Denies Mylan Inc. Motion for Interim Injunction
10/28/2010
-
Mylan Inc. Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65
10/27/2010
-
Mylan Inc. and Mylan Charitable Foundation Award a Collective $1.25 Million to Prominent West Virginia Cultural Institutions
10/22/2010
-
Mylan Inc. Receives Approval for Generic Version of Mirapex(R) Tablets
10/21/2010
-
Mylan Inc. Declares Quarterly Preferred Stock Dividend
10/20/2010
-
Mylan Inc. to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case
10/19/2010
-
Mylan Inc. Schedules Third Quarter 2010 Financial Results Conference Call and Live Webcast
10/19/2010
-
Mylan Inc. Receives Approvals for Generic Versions of Hyzaar(R) and Cozaar(R)
10/15/2010
-
Mylan Inc.'s Matrix Receives Tentative FDA Approval Under PEPFAR for Generic Version of Reyataz(R) Capsules HIV Treatment
10/5/2010
-
Mylan Inc. Receives Approval for Fludarabine Phosphate Injection, USP
10/4/2010
-
Mylan Inc. Launches Generic Version of Wellbutrin XL(R) Tablets
10/1/2010
-
Mylan Inc. Gets Order Blocking GlaxoSmithKline and Apotex Corp. Supply, Sale and/or Importing of a Generic Version of Paxil CR
9/22/2010
-
Mylan Inc. Receives Approval for Generic Version of Prograf(R) Capsules
9/21/2010
-
Mylan Inc. Completes Acquisition of Bioniche Pharma USA LLC Sooner Than Expected
9/7/2010
-
U.S. Court of Appeals Upholds Validity of Eli Lilly and Company's Evista Patents Through March of 2014; Mylan Inc. And Teva Pharmaceutical Industries Limited Affected
9/1/2010
-
Mylan Inc. Announces Completion of Add-On Offering of Senior Notes
8/16/2010
-
Mylan Inc. Announces Pricing of Add-On Offering of Senior Notes
8/2/2010
-
Mylan Inc. Announces Proposed Add-On Private Placement of its Senior Notes Due 2020
7/30/2010
-
Mylan Inc. Reports Adjusted Diluted EPS of $0.37 for the Three Months Ended June 30, 2010
7/29/2010